Chemoinformaics analysis of Artedouglasia oxide D
| Molecular Weight | 250.338 | nRot | 2 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 13 |
| Exact Molecular Weight | 250.157 | nRing | 2 |
| Solubility: LogS | -2.41 | nHRing | 2 |
| Solubility: LogP | 2.63 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 42.1254 |
| nHD | 0 | BPOL | 26.4106 |
| QED | 0.707 |
| Synth | 4.654 |
| Natural Product Likeliness | 3.14 |
| NR-PPAR-gamma | 0.295 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.816 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.404 |
| MDCK | 0.0000384 |
| BBB | 0.729 |
| PPB | 0.789242 |
| VDSS | 1.559 |
| FU | 0.271351 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.884 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.879 |
| CYP2c9-inh | 0.052 |
| CYP2c9-sub | 0.056 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.084 |
| CYP3a4-inh | 0.624 |
| CYP3a4-sub | 0.817 |
| CL | 11.021 |
| T12 | 0.319 |
| hERG | 0.022 |
| Ames | 0.05 |
| ROA | 0.588 |
| SkinSen | 0.812 |
| Carcinogencity | 0.894 |
| EI | 0.215 |
| Respiratory | 0.964 |
| NR-Aromatase | 0.62 |
| Antiviral | Yes |
| Prediction | 0.894734 |